Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference
EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, and Michael P. Smith, Executive Vice President, Chief Financial Officer & Treasurer and Secretary, will present a corporate update at the Leerink Partners 7th Annual Global Healthcare Conference, being held in New York City from February 14-15, 2018.
Leerink Partners 7thAnnual Annual Global Healthcare Conference -- Zogenix Presentation Details
Date: Thursday, February 15, 2018
Time: 9:00 am Eastern Time / 6:00 am Pacific Time
Location: New York, NY - Lotte New York Palace Hotel
The presentation will be webcast live and archived for 90 days on Zogenix's Investor Relations website at https://zogenixinc.gcs-web.com/.
About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Investors: Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987 | Andrew@lifesciadvisors.com